Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label rollover study of idelalisib for subjects previously treated with GS-9820
2015-005766-39Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of idelalisib in lymphoma, hematopoietic malignancies and cancer, sponsored by Gilead Sciences. Started Feb 2016; status: completed.
02
Drugs
idelalisib
03
Conditions
lymphomahematopoietic malignanciescancer
Beyond the preview
Go deeper on 2015-005766-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005766-39.